Logo image of RAD

RITE AID CORP (RAD) Stock Price, Quote, News and Overview

NYSE:RAD - New York Stock Exchange, Inc. - US7677548726 - Common Stock - Currency: USD

0.6483  -0.13 (-16.81%)

Premarket: 0.6121 -0.04 (-5.58%)

RAD Quote, Performance and Key Statistics

RITE AID CORP

NYSE:RAD (10/13/2023, 8:15:35 PM)

Premarket: 0.6121 -0.04 (-5.58%)

0.6483

-0.13 (-16.81%)

Sector
GICS SectorConsumer Staples
GICS IndustryConsumer Staples Distribution & Retail
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS SubIndustryDrug Retail
Statistics
52 Week High7.37
52 Week Low0.38
Market Cap36.76M
Shares56.70M
Float55.04M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)12-19 2023-12-19/bmo
IPO05-22 1981-05-22


RAD short term performance overview.The bars show the price performance of RAD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40 -60

RAD long term performance overview.The bars show the price performance of RAD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of RAD is 0.6483 USD. In the past month the price decreased by -2.92%. In the past year, price decreased by -83.2%.

RITE AID CORP / RAD Daily stock chart

RAD Competitors/Peers

The largest stocks on the US markets in the "Drug Retail" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
WBA WALGREENS BOOTS ALLIANCE INC 3.72 8.78B
GRDN GUARDIAN PHRMCY SERVICES-A N/A 1.24B
YI 111 INC N/A 71.62M
MGRX MANGOCEUTICALS INC N/A 13.34M
CJJD CHINA JO-JO DRUGSTORES HOLDI N/A 8.53M

About RAD

Company Profile

RAD logo image Rite Aid Corp. engages in the ownership and management of retail drug stores. The company is headquartered in Philadelphia, Pennsylvania and currently employs 47,000 full-time employees. The firm is engaged in providing its services to customers and communities through various programs. The company operates through two segments: the Retail Pharmacy segment and the Pharmacy Services segment. The Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. The Pharmacy Services Segment, which consists of Elixir, its pharmacy benefit management (PBM) business, provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network, and rebate administration, claims adjudication, and pharmacy discount programs. Elixir also provides prescription discount programs and Medicare Part D insurance offerings for individuals and groups. The company operates over 2,300 retail pharmacy locations across 17 states.

Company Info

RITE AID CORP

1200 Intrepid Avenue, 2nd Floor

PHILADELPHIA PENNSYLVANIA 17011 US

CEO: Heyward Donigan

Employees: 47000

Company Website: https://www.riteaid.com/

Phone: 17177612633.0

RITE AID CORP / RAD FAQ

What is the stock price of RITE AID CORP today?

The current stock price of RAD is 0.6483 USD. The price decreased by -16.81% in the last trading session.


What is the ticker symbol for RITE AID CORP stock?

The exchange symbol of RITE AID CORP is RAD and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is RAD stock listed?

RAD stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for RITE AID CORP stock?

10 analysts have analysed RAD and the average price target is 1.02 USD. This implies a price increase of 57.33% is expected in the next year compared to the current price of 0.6483. Check the RITE AID CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is RITE AID CORP worth?

RITE AID CORP (RAD) has a market capitalization of 36.76M USD. This makes RAD a Nano Cap stock.


How many employees does RITE AID CORP have?

RITE AID CORP (RAD) currently has 47000 employees.


What are the support and resistance levels for RITE AID CORP (RAD) stock?

RITE AID CORP (RAD) has a resistance level at 1.04. Check the full technical report for a detailed analysis of RAD support and resistance levels.


Is RITE AID CORP (RAD) expected to grow?

The Revenue of RITE AID CORP (RAD) is expected to decline by -3.31% in the next year. Check the estimates tab for more information on the RAD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy RITE AID CORP (RAD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does RITE AID CORP (RAD) stock pay dividends?

RAD does not pay a dividend.


When does RITE AID CORP (RAD) report earnings?

RITE AID CORP (RAD) will report earnings on 2023-12-19, before the market open.


What is the Price/Earnings (PE) ratio of RITE AID CORP (RAD)?

RITE AID CORP (RAD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.74).


RAD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

RAD Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to RAD. RAD may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RAD Financial Highlights

Over the last trailing twelve months RAD reported a non-GAAP Earnings per Share(EPS) of -2.74. The EPS decreased by -10.04% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -12.37%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-21.67%
Sales Q2Q%-6.01%
EPS 1Y (TTM)-10.04%
Revenue 1Y (TTM)-2.83%

RAD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 42% to RAD. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of -86.91% and a revenue growth -3.31% for RAD


Ownership
Inst Owners0%
Ins Owners153.29%
Short Float %N/A
Short RatioN/A
Analysts
Analysts42
Price Target1.02 (57.33%)
EPS Next Y-86.91%
Revenue Next Year-3.31%